Episode Details
Back to Episodes
215: COVID-19 Testimony
Episode 215
Published 6 years, 3 months ago
Description
When Congress (finally) returned from their COVIDcation, experts in medicine, vaccine development, law, and business testified under oath. In this episode, hear the highlights from 17 hours of that expert testimony during which you'll learn about a concerning new vaccine development policy, Mitch McConnell's dangerous demands for the next COVID-19 response law, and how Republicans and Democrats failed for the last two decades to secure the nation's medical mask supply. Thank you to all Congressional Dish producers who make the independence of this podcast possible. Enjoy your show! Please Support Congressional Dish – Quick Links Click here to contribute monthly or a lump sum via PayPal Click here to support Congressional Dish for each episode via Patreon Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: 5753 Hwy 85 North, Number 4576, Crestview, FL 32536 Please make checks payable to Congressional Dish Thank you for supporting truly independent media! Articles/Documents Article: Scientists Worldwide Are Questioning A Massive Study That Raised Concerns About The Malaria Drug Hyped As A COVID-19 Treatment By Stephanie M. Lee, Buzz Feed News, May 30, 2020 Article: CORPORATE IMMUNITY, MITCH MCCONNELL'S PRIORITY FOR CORONAVIRUS RELIEF, IS A LONGTIME FOCUS OF THE CONSERVATIVE RIGHT By Akela Lacy, The Intercept, May 26, 2020 Press Release: Trump Administration's Operation Warp Speed Accelerates AstraZeneca COVID-19 Vaccine to be Available Beginning in October, U.S. Department of Health and Human Services, May 21, 2020 Article: Social Distancing Is Not Enough By Derek Thompson, The Atlantic, May 22, 2020 Article: Federal agency finds 'reasonable grounds to believe' Rick Bright's whistleblower claims: NYT By Eric Sagonowsky, Fierce Pharma, May 8, 2020 Article: McConnell's coronavirus business liability pledge sparks lobbying frenzy By Jennifer Haberkorn, Los Angeles Times, May 6, 2020 Article: FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems, U.S. Food & Drug Administration, April 24, 2020 Article: As workers face virus risks, employers seek liability limits By Emily Kopp, Roll Call, April 17, 2020 Article: Hydroxychloroquine: how an unproven drug became Trump's coronavirus 'miracle cure' By Julia Carrie Wong, The Guardian, April 17, 2020 Article: Sunlight exposure increased Covid-19 recovery rates: A study in the central pandemic area of Indonesia By Al Asyary and Merita Veruswati, ScienceDirect, Elsevier, 10 April 2020 Resources Tweet @JenBriney, Jennifer Briney, Twitter, May 27, 2020 Sound Clip Sources News Alert: Trump says he's taking hydroxychloroquine despite FDA warnings, Axios, Fox News, May 18, 2020 Interview: McConnell says next stimulus must have coronavirus liability protections, By Noah Manskar, The New York Post, Fox News, May 15, 2020 Hearing: Protecting Scientific Integrity in the COVID-19 Response, United States House Committee on Energy and Commerce Subcommittee on Health, May 14, 2020 Watch on Youtube Watch on CSPAN Witnesses: Dr. Richard Bright - Former Director of BARDA, current Senior Advisor at the National Institutes of Health Mike Bowen - Executive Vice President of Prestige Ameritech Transcript: 51:40 Rep. Ana Eshoo (CA): Was there a failure to respond with the needed urgency when you correctly pushed to ramp up production of masks, respirators, syringes, swabs. Dr. Rick Bright: Congresswoman, we've known for quite some time that our stockpile is insufficient and having those critical personal protective equipment. So once this virus began spreading and became known to be a threat, I did feel quite concerned that we didn't have those supplies. I began pushing urgently in January along with some industry col